STOCK TITAN

Verano Hldgs reported $821.5M in revenue and a $258K net loss for fiscal 2025. See the full VRNO financial statements: income statement, balance sheet, cash flow and ratios, each column linked to its SEC filing.

Verano Announces Upcoming Conference Participation

Verano’s executive leadership plans to attend the Sept. 9, 2026 ATB Cormark conference in NYC and hold investor meetings.

(Moderate)
(Neutral)
Tags
conferences

Verano (VRNO) will participate in the ATB Cormark Cannabis Institutional Investor Conference 2026 on September 9, 2026, in New York City. Members of the executive leadership team plan to attend and hold investor meetings during the event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – VRNO

+1.17%
+1.17% Session close to close

In the Sep 2 session, VRNO gained 1.17%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CHICAGO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will attend the following conference:

ATB Cormark Cannabis Institutional Investor Conference 2026
Verano management will participate in investor meetings.
DATE: September 9, 2026
LOCATION: New York City, NY

About Verano

Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO), one of the U.S. cannabis industry’s leading companies based on historical revenue, geographic scope and brand performance, is a vertically integrated, multi-state operator embracing a mission of saying Yes to plant progress and the bold exploration of cannabis. Verano provides a superior cannabis shopping experience in medical and adult use markets under the Zen Leaf and MÜV dispensary banners, and produces a comprehensive suite of high-quality, regulated cannabis products sold under its diverse portfolio of trusted consumer brands including Savvy, (the) Essence, Swift Lifts, HYPHEN, Encore, Easy Landings, BITS, Avexia, MÜV, CTPharma, and Verano. Verano’s active operations span 13 U.S. states, comprised of 14 production facilities with over 1.1 million square feet of cultivation capacity. Learn more at Verano.com.

Contacts:
Investors
Verano
Aaron Miles
Chief Investment Officer
Investors@verano.com

Media
Verano
Steve Mazeika
Vice President, Communications
steve.mazeika@verano.com

Forward Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans, strategies, or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “future”, “scheduled”, “estimates”, “forecasts”, “projects,” “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking statements herein, including, without limitation, the risk factors described in the Company’s annual report on Form 10-K for the year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission at www.sec.gov. The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information or forward-looking statements that are contained or referenced herein, except as may be required in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or persons acting on its behalf is expressly qualified in its entirety by this notice regarding forward-looking information and statements.

##


FAQ

What conference will Verano (VRNO) attend in September 2026?

Verano will attend the ATB Cormark Cannabis Institutional Investor Conference 2026. Members of the company’s executive leadership team are expected to participate and meet with investors during the event.

When is Verano (VRNO) scheduled to participate in the ATB Cormark Cannabis Institutional Investor Conference 2026?

Verano is scheduled to participate in the ATB Cormark Cannabis Institutional Investor Conference 2026 on September 9, 2026. The event will take place in New York City, New York.

Where will Verano (VRNO) meet investors during the ATB Cormark conference?

Verano management will participate in investor meetings at the ATB Cormark Cannabis Institutional Investor Conference 2026, which will be held in New York City, NY.

Who can investors contact at Verano (VRNO) regarding the September 2026 conference?

Investors can contact Aaron Miles, Chief Investment Officer at Verano, via Investors@verano.com for inquiries related to the company and its investor activities, including the September 2026 conference.